This tool is not intended for reporting adverse events or product complaints related to Boehringer Ingelheim products and may, accordingly, not be regularly monitored. If you need to report an adverse event or product complaint related to a Boehringer Ingelheim product, please follow the local processes which are outlined in the package insert or use the reporting contact details included in this website. For any adverse events please contact Boehringer Ingelheim’s responsible Pharmacovigilance unit use the below contact details.
Email Address: PV_local_ROPU_MENA@boehringer-ingelheim.com
Mobile: +97155 9865722
Boehringer Ingelheim Middle East, Turkey & Africa Regional Offices, Index Tower, Level 13, Dubai International Financial Center (DIFC) P.O. Box 507066, Dubai, United Arab Emirates Document Boehringer Ingelheim takes the protection of your personal data seriously and we have policies and procedures in place to protect your personal information, in order to comply with our internal Data Protection Standards as well as applicable Data Protection Laws. As part of our continuous efforts to provide you with relevant scientific information pertaining to our product portfolio or relevant diseases estates we may collect personal data from you (e.g. business emails, telephone/mobile numbers, fax and postal addresses) and we may also disclose such personal data to Boehringer Ingelheim group companies globally and also to third parties who are involved in sending you information on behalf of Boehringer Ingelheim.
You may withdraw your consent at any time to the collection, use and disclosures of your personal data for the purposes stated above by contacting the Data Protection Officer at METAdataprotection.AE@boehringer-ingelheim.com or click this link to Unsubscribe. PC-AE-101927.